Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00506948
Status:
TERMINATED
Last Update Posted:
2020-09-24
First Post:
2007-07-20
Brief Title:
Thymoglobulin Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease GVHD
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Hematological Malignancies |
| Myelodysplastic Syndrome |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| MMF | View |
| Hematological Malignancies | View |
| Myelodysplastic Syndrome | View |
| Graft Versus Host Disease | View |
| GVHD | View |
| Allogeneic Hematopoietic Stem Cell Transplantation | View |
| AHSCT | View |
| Leukemia | View |
| Lymphoma | View |
| T-Cells | View |
| Thymoglobulin | View |
| ATG | View |
| rATG | View |
| Rabbit Antithymocyte Globulin | View |
| Rapamune | View |
| Sirolimus | View |
| Mycophenolate Mofetil | View |
| Cellcept | View |